[{"id":5889,"regimens":[{"id":11001,"duration":{"id":5059,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":11228,"name":"Tenofovir Disoproxil Fumarate","url":"cure-api2.ncats.io/v1/drugs/11228","rxNorm_id":null,"notes":null},"use_drug":[{"id":7304,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11001},{"id":7305,"answer":"In a novel combination with another drug","answer_other":"","regimen":11001}],"created":"2020-09-13T22:26:47.411837Z","updated":"2020-10-06T22:14:52.041399Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11002,"duration":{"id":5060,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":7601,"name":"Emtricitabine","url":"cure-api2.ncats.io/v1/drugs/7601","rxNorm_id":null,"notes":null},"use_drug":[{"id":7306,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11002},{"id":7307,"answer":"In a novel combination with another drug","answer_other":"","regimen":11002}],"created":"2020-09-13T22:26:47.419432Z","updated":"2020-10-06T22:14:52.047802Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11003,"duration":{"id":5061,"approximate_duration":"14 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":7308,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11003},{"id":7309,"answer":"In a novel combination with another drug","answer_other":"","regimen":11003}],"created":"2020-09-13T22:26:47.425423Z","updated":"2020-10-06T22:14:52.053618Z","dose":"400/100 mg","frequency":"BD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11004,"duration":{"id":5062,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":7310,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11004},{"id":7311,"answer":"In a novel combination with another drug","answer_other":"","regimen":11004}],"created":"2020-09-13T22:26:47.431887Z","updated":"2020-10-06T22:14:52.059388Z","dose":"400 mg twice a day with a loading dose on the first day and then 200 mg twice a day for 4 days","frequency":"BD","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5889},{"id":11005,"duration":{"id":5063,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":7312,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11005},{"id":7313,"answer":"In a novel combination with another drug","answer_other":"","regimen":11005}],"created":"2020-09-13T22:26:47.438508Z","updated":"2020-10-06T22:14:52.065071Z","dose":"","frequency":"","route":"inhaled","severity":"Inpatient","severity_detail":"","comments":null,"report":5889}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7704,"answer":"Clinical assessment","answer_other":"","report":5889}],"how_diagnosis":[{"id":13102,"answer":"Clinical assessment","answer_other":"","report":5889},{"id":13103,"answer":"Imaging","answer_other":"","report":5889},{"id":13104,"answer":"PCR","answer_other":"","report":5889}],"author_username":"Reema Charles","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3820,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5889}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":192,"answer":"White","answer_other":""}],"created":"2020-09-13T22:24:35.370712Z","updated":"2020-10-06T22:14:52.033387Z","title":"COVID-19 in patients with HIV: clinical case series. Case 4","status":"Approved","anonymous":false,"published":true,"pubmed_id":32304642,"doi":"10.1016/S2352-3018(20)30111-9","article_url":"https://pubmed.ncbi.nlm.nih.gov/32304642/","pub_year":2020,"published_authors":"Blanco JL\r\nAmbrosioni J\r\nGarcia F\r\nMartínez E\r\nSoriano A\r\nMallolas J\r\nMiro JM\r\nCOVID-19 in HIV Investigators.","article_author_email":"Author email could not be found.","journal":"The lancet. HIV","abstract":"On March 9, 2020, 2 weeks into the COVID-19 outbreak in Spain, 543 consecutive patients with SARS-CoV-2 infection had been admitted to hospital at Hospital Clínic Barcelona, Barcelona, Spain. We admitted 62 (12%) into intensive care units and we discharged 208 (38%) with supervised outpatient care. Of all patients, five (0·92%; 95% 0·39–2·14) were HIV positive, of whom three were male and two were transgender, and four identified as men who have sex with men (MSM). Two patients had comorbid conditions.","article_type":"Original","study_type":"Case Report","number_of_patients":5,"article_patient_number":"4","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Hispanic/Latino","country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":true,"asthma":true,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"ART - Abacavir, lamivudine; and dolutegravir","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"MSM, sexual worker participant in ChemSex session 6 days before. \r\n\r\nART admission - Tenofovir disoproxil fumarate, and emtricitabine plus lopinavir-boosted ritonavir (for 14 days).\r\n\r\nRight basal interstitial infiltrate\r\n\r\nLength of hospital stay (days) - 4\r\n\r\nConcomitant antibacterials (Azithromycin and Cefixime) for pneumonia","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,7601,8342,8783,11228]}]